• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Friday, August 19, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Research team wins NIH prize for plan to accelerate advances in spinal stimulation through autonomic neuromodulation

Bioengineer by Bioengineer
July 22, 2022
in Chemistry
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

East Hanover, NJ. July 22, 2022. The pioneering collaborative work being performed by Kessler Foundation scientists in the Tim and Caroline Reynolds Center for Spinal Stimulation team has been recognized with the Neuromod Prize, a new initiative from the National Institutes of Health (NIH) Common Fund’s Stimulating Peripheral Activity to Relieve Conditions (SPARC) program. The Neuromod Prize aims to accelerate the development of neuromodulation therapies — targeted treatments that have the potential to treat a multitude of conditions through regulation of nervous system activity. The competition capitalizes on the rapid momentum in the field as innovators apply decades of research to the development of novel neuromodulation solutions to clinical challenges.

Neuromod Prize logo

Credit: NIH Common Fund

East Hanover, NJ. July 22, 2022. The pioneering collaborative work being performed by Kessler Foundation scientists in the Tim and Caroline Reynolds Center for Spinal Stimulation team has been recognized with the Neuromod Prize, a new initiative from the National Institutes of Health (NIH) Common Fund’s Stimulating Peripheral Activity to Relieve Conditions (SPARC) program. The Neuromod Prize aims to accelerate the development of neuromodulation therapies — targeted treatments that have the potential to treat a multitude of conditions through regulation of nervous system activity. The competition capitalizes on the rapid momentum in the field as innovators apply decades of research to the development of novel neuromodulation solutions to clinical challenges.

Kessler Foundation and the University of Louisville, in collaboration with technological partners Medtronic and the Johns Hopkins Applied Physics Lab, comprised one of the eight teams (out of 45 applicants) to win Phase 1 of this competition. Each winning Phase 1 team received $100,000 and an exclusive invitation to compete in Phase 2 proof-of-concept studies, for which up to four winning teams will share a prize pool of $4 million. Then, the Phase 2 winning teams will be invited to participate in Phase 3, where up to two winners will split a prize pool of $5 million.

The team’s winning proposal, which outlines a pathway to greater independence for individuals paralyzed by spinal cord injury, is titled, “Neuromodulation of the lumbosacral spinal cord for improvement of autonomic function after spinal cord injury.”

While gaining voluntary control over paralyzed or weakened limbs is a major focus of the team’s research, spinal cord injury is complex, disrupting motor and sensory pathways, as well as the autonomic nervous system that regulates heart rate, blood pressure, breathing, balance, bowel and bladder control, and sexual function. Building on their advances in restoring motor function through epidural stimulation, the team’s Neuromod Prize entry proposed the development of a novel tablet-type controller called StimXS, which will help individuals with implanted epidural stimulators continuously stabilize their blood pressure and improve their respiratory and bladder function.

For people paralyzed by spinal cord injury, the implications are tremendous, according to Gail Forrest, PhD, director of the Reynolds Center for Spinal Stimulation and associate director of the Center for Mobility and Rehabilitation Engineering Research at Kessler Foundation.

“Using this one handheld controller, individuals with paralysis will be able to direct stimulation to move their limbs, empty their bladder, and control their blood pressure and breathing,” Dr. Forrest explained. “And because the tablet can be used with limited hand function, individuals with spinal cord injury will gain independence from family and caregivers. By collecting usage data, the StimXS will gather valuable information on how individuals use stimulation in their daily lives,” she added, “and guide our efforts to address a broader range of autonomic deficits through neuromodulation.”  

“Being among the Phase 1 winners of this prestigious prize spotlights the exceptional progress being made by our unique interdisciplinary team of researchers,” said Steven Kirshblum, MD, co-director of the Reynolds Center and chief medical officer of Kessler Foundation and Kessler Institute for Rehabilitation. “By broadening the scope of our research in spinal stimulation, the Neuromod Prize is supporting research that promises to revolutionize the outlook for people with spinal cord injury.

The team’s spinal stimulation research has received private and public support, including Kessler Foundation, the Tim and Caroline Reynolds Foundation, Reeve Foundation, the Neilsen Foundation, the Helmsley Charitable Trust, the New Jersey Commission on Spinal Cord Research, and federal grants.

About Kessler Foundation

Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research that seeks to improve cognition, mobility and long-term outcomes, including employment, for people with neurological disabilities caused by diseases and injuries of the brain and spinal cord. Kessler Foundation leads the nation in funding innovative programs that expand opportunities for employment for people with disabilities. For more information, visit KesslerFoundation.org.

Stay Connected

Twitter | Facebook | YouTube | Instagram | iTunes & SoundCloud

Press contacts:

Deb Hauss, senior staff writer, 973.324.8372, [email protected]

Carolann Murphy, senior medical writer, [email protected]

 

 

 

 



Share12Tweet7Share2ShareShareShare1

Related Posts

Crystal structure of TbMn6Sn6

A breakthrough in magnetic materials research could lead to novel ways to manipulate electron flow with much less energy loss

August 18, 2022
Light in Soybean Canopy

RIPE researchers prove bioengineering better photosynthesis increases yields in food crops for the first time ever

August 18, 2022

Engineers fabricate a chip-free, wireless electronic “skin”

August 18, 2022

Exploring quantum electron highways with laser light

August 18, 2022

POPULAR NEWS

  • Picture of the horse specimen.

    Ancient DNA clarifies the early history of American colonial horses

    57 shares
    Share 23 Tweet 14
  • Fatigue, headache among top lingering symptoms months after COVID

    40 shares
    Share 16 Tweet 10
  • Chi-Huey Wong awarded Tetrahedron Prize for Creativity in Organic Synthesis

    38 shares
    Share 15 Tweet 10
  • The protein signature changes during heart disease caused by reductive stress

    34 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

University of WashingtonVaccineVirusViolence/CriminalsUrogenital SystemWeather/StormsUrbanizationZoology/Veterinary ScienceWeaponryVehiclesVaccinesVirology

Recent Posts

  • Collaborations inspired early-career NIH grant that could lead to treatment breakthroughs for a range of medical conditions
  • Novel hypotheses that answer key questions about the evolution of sexual reproduction
  • Medieval friars were ‘riddled with parasites’, study finds
  • A breakthrough in magnetic materials research could lead to novel ways to manipulate electron flow with much less energy loss
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In